Solventum (SOLV) Stock Forecast: StockMap's 2-Week Call
SOLV stock forecast: StockMap's model makes no two-week call on Solventum after the Nov 19 close: its evidence is split, 4 reasons for and 11 against. Right in 1 of 3 two-week windows on SOLV since Aug 21; by chance, a call on the same dates was right 62% of the time.
Solventum last closed at $85.80, -0.79% on the session.
Against the IVW growth benchmark the position is +1.54% over the forecast window.
Solventum's market cap is $14.56B as of November 19, 2026, #442 in the S&P 500.
No call today: the model sees no clear direction · the next 2 weeks, vs S&P 500 growth. The lean on a scale from −100 to +100 is -6 (too close to call).
Where SOLV sits: sized by market cap, coloured by the day's move.
The read is built from 15 underlying insights — 4 bullish and 11 bearish.
Agreement across those insights is 73%.
10 daily calls for SOLV so far. We publish our accuracy across thousands of stocks in the open, misses included — no per-stock hit rate is claimed on a small sample.
On the fundamentals StockMap ranks Solventum in the 5th percentile on valuation and the 44th percentile on return on equity, where 100 is best.
Solventum is classified under Health Care / Health Care Equipment & Supplies.
StockMap tracks Solventum as the 17th largest of the 141 companies it covers in the Health Care Equipment & Supplies industry, part of the Health Care sector.
Across that group the current two-week reads are 69 Neutral, 55 Moderate Underperform, 14 Strong Underperform and 3 Moderate Outperform.
On that composite Solventum ranks 42nd of 141 in the group, against a group median of -0.18.